MoneyWorks4Me

Cipla informs about press release

25 Jul 2019 Evaluate

Cipla has informed that it has enclosed press release titled 'Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI (IV Plazomicin).'.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..